XML 35 R21.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule II - Valuation and Qualifying Accounts
 12 Months Ended
Jan. 02, 2021
Notes to Financial Statements  
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

(in thousands)

 

Description

 

Balance at beginning of period

  

Charged to costs and expenses

  

Deductions

  

Balance at end of period

 
                 

January 2, 2021

                

Allowance for sales returns

 $772  $115  $68  $819 

Allowance for doubtful accounts

 $261  $131  $20  $372 

Valuation allowance - deferred tax assets

 $64,285  $17,116  $-  $81,401 
                 

December 28, 2019

                

Allowance for sales returns

 $839  $168  $235  $772 

Allowance for doubtful accounts

 $139  $146  $24  $261 

Valuation allowance - deferred tax assets

 $44,199  $20,086  $-  $64,285 
                 

December 29, 2018

                

Allowance for sales returns

 $632  $307  $100  $839 

Allowance for doubtful accounts

 $325  $8  $194  $139 

Valuation allowance - deferred tax assets

 $13,980  $30,219  $-  $44,199